Bokf Na raised its position in shares of Cigna Corp (NYSE:CI) by 70.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 14,147 shares of the health services provider’s stock after acquiring an additional 5,841 shares during the period. Bokf Na’s holdings in Cigna were worth $2,687,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently bought and sold shares of the business. Mascoma Wealth Management LLC grew its holdings in shares of Cigna by 8.1% in the fourth quarter. Mascoma Wealth Management LLC now owns 709 shares of the health services provider’s stock worth $135,000 after purchasing an additional 53 shares during the last quarter. Howe & Rusling Inc. grew its holdings in shares of Cigna by 1.3% in the fourth quarter. Howe & Rusling Inc. now owns 4,585 shares of the health services provider’s stock worth $871,000 after purchasing an additional 61 shares during the last quarter. First Command Bank grew its holdings in shares of Cigna by 11.8% in the fourth quarter. First Command Bank now owns 636 shares of the health services provider’s stock worth $121,000 after purchasing an additional 67 shares during the last quarter. First Command Financial Services Inc. grew its holdings in shares of Cigna by 11.8% in the fourth quarter. First Command Financial Services Inc. now owns 636 shares of the health services provider’s stock worth $121,000 after purchasing an additional 67 shares during the last quarter. Finally, First Financial Corp IN grew its holdings in shares of Cigna by 10.1% in the fourth quarter. First Financial Corp IN now owns 786 shares of the health services provider’s stock worth $150,000 after purchasing an additional 72 shares during the last quarter. Institutional investors and hedge funds own 93.44% of the company’s stock.

A number of research analysts have recently commented on CI shares. ValuEngine cut shares of Cigna from a “hold” rating to a “sell” rating in a report on Thursday, February 28th. Morgan Stanley cut their price target on shares of Cigna from $304.00 to $299.00 and set an “overweight” rating on the stock in a report on Tuesday, February 5th. Goldman Sachs Group restated a “buy” rating on shares of Cigna in a report on Saturday, February 2nd. Barclays restated a “buy” rating and issued a $220.00 price target on shares of Cigna in a report on Sunday, January 6th. Finally, Edward Jones started coverage on shares of Cigna in a report on Wednesday, January 2nd. They issued a “buy” rating on the stock. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and thirteen have given a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $231.28.

In other Cigna news, Director John Partridge sold 1,000 shares of the stock in a transaction dated Thursday, February 7th. The shares were sold at an average price of $184.43, for a total transaction of $184,430.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Brian C. Evanko purchased 2,000 shares of the firm’s stock in a transaction on Monday, March 11th. The shares were purchased at an average cost of $163.40 per share, with a total value of $326,800.00. The disclosure for this purchase can be found here. 1.10% of the stock is owned by corporate insiders.

Shares of Cigna stock opened at $169.56 on Friday. The company has a current ratio of 0.42, a quick ratio of 0.42 and a debt-to-equity ratio of 0.96. Cigna Corp has a 1 year low of $162.42 and a 1 year high of $226.60. The stock has a market cap of $64.80 billion, a price-to-earnings ratio of 11.92, a price-to-earnings-growth ratio of 0.81 and a beta of 0.73.

Cigna (NYSE:CI) last issued its earnings results on Friday, February 1st. The health services provider reported $2.46 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $2.53 by ($0.07). Cigna had a return on equity of 16.64% and a net margin of 5.42%. The business had revenue of $13.75 billion for the quarter, compared to the consensus estimate of $11.38 billion. During the same quarter in the previous year, the company earned $1.94 earnings per share. The firm’s revenue was up 29.3% on a year-over-year basis. As a group, equities research analysts forecast that Cigna Corp will post 16.41 earnings per share for the current fiscal year.

The firm also recently announced a special dividend, which will be paid on Wednesday, April 10th. Shareholders of record on Monday, March 11th will be issued a dividend of $0.04 per share. The ex-dividend date of this dividend is Friday, March 8th. Cigna’s payout ratio is 0.28%.

COPYRIGHT VIOLATION NOTICE: “Bokf Na Has $2.69 Million Holdings in Cigna Corp (CI)” was posted by TheOlympiaReport and is owned by of TheOlympiaReport. If you are viewing this report on another publication, it was illegally stolen and republished in violation of United States & international copyright laws. The original version of this report can be viewed at https://theolympiareport.com/2019/03/15/bokf-na-has-2-69-million-holdings-in-cigna-corp-ci.html.

About Cigna

Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. It operates through Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations segments. The Global Health Care segment offers medical, dental, behavioral health, vision, and prescription drug benefit plans, as well as health advocacy programs, and other products and services to insured and self-insured customers.

Featured Article: Fundamental Analysis – How It Helps Investors

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corp (NYSE:CI).

Institutional Ownership by Quarter for Cigna (NYSE:CI)

Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.